|
Volume 271, Number 51,
Issue of December 20, 1996
pp. 32960-32967
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Molecular Cloning and Characterization of CFT1, a
Developmentally Regulated Avian (1,3)-Fucosyltransferase Gene
(Received for publication, July 3, 1996, and in revised form, September 17, 1996)
Kelvin P.
Lee
,
Louise M.
Carlson
¶
,
Juliana B.
Woodcock
,
Nandini
Ramachandra
,
Terrie L.
Schultz
**
,
Thomas A.
Davis
,
John B.
Lowe
 
,
Craig B.
Thompson
§§
and
Robert D.
Larsen
**
From the Immune Cell Biology Program, Naval Medical
Research Institute, Bethesda, Maryland 20889, ¶ NIAID, National
Institutes of Health, Bethesda, Maryland 20892, the Howard
Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan
48109, ** Glycomed Inc., Alameda, California 94501, the
 Department of Pathology, University of
Michigan, Ann Arbor, Michigan 48109, and the
§§ Gwenn Knapp Center for Lupus and Immunology
Research, Department of Medicine, Department of Molecular Genetics and
Cell Biology, Howard Hughes Medical Institute, University of Chicago,
Chicago, Illinois 60637
Although coordinate expression of carbohydrate
epitopes during development is well described, mechanisms which
regulate this expression remain largely unknown. In this study we
demonstrate that developing chicken B cells express the
LewisX terminal oligosaccharide structure in a
stage-specific manner. To examine regulation of this expression, we
have cloned and expressed the chicken (1,3)-fucosyltransferase gene
involved in LewisX biosynthesis, naming it chicken
fucosyltransferase 1 (CFT1). CFT1 is
characterized by a single long open reading frame of 356 amino acids
encoding a type II transmembrane glycoprotein. The domain structure and
predicted amino acid sequence are highly conserved between
CFT1 and mammalian FucTIV genes (52.8% and
46.3% identity to mouse and human respectively). In vitro
CFT1 fucosyltransferase activity utilizes LacNAc > 3 sialyl-LacNAc acceptors with almost no utilization of other neutral
type II (lactose, 2-fucosyllactose), or type I
(lacto-N-biose I) acceptors. CFT1-transfected
cells make cell surface LewisX (COS-7) and
LewisX + VIM-2 structures (Chinese hamster ovary).
CFT1 gene expression is tissue-specific and includes
embryonic thymus and bursa. Furthermore, expression of the
CFT1 gene and cell surface LewisX structures
are closely linked during B cell development. These findings reveal the
evolutionary conservation between nonmammalian and mammalian
(1,3)-fucosyltransferase genes and demonstrate a role for
fucosyltransferase gene regulation in the developmental expression of
oligosaccharide structures.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Jost, T. de Vries, R. M.A. Knegtel, and B. A. Macher
Mutation of amino acids in the alpha 1,3-fucosyltransferase motif affects enzyme activity and Km for donor and acceptor substrates
Glycobiology,
February 1, 2005;
15(2):
165 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Sherwood, D. A. Upchurch, M. R. Stroud, W. C. Davis, and E. H. Holmes
A highly conserved His-His motif present in {alpha}1->3/4fucosyltransferases is required for optimal activity and functions in acceptor binding
Glycobiology,
October 1, 2002;
12(10):
599 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dupuy, J.-M. Petit, R. Mollicone, R. Oriol, R. Julien, and A. Maftah
A Single Amino Acid in the Hypervariable Stem Domain of Vertebrate alpha 1,3/1,4-Fucosyltransferases Determines the Type 1/Type 2 Transfer. CHARACTERIZATION OF ACCEPTOR SUBSTRATE SPECIFICITY OF THE LEWIS ENZYME BY SITE-DIRECTED MUTAGENESIS
J. Biol. Chem.,
April 30, 1999;
274(18):
12257 - 12262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kudo, Y. Ikehara, A. Togayachi, M. Kaneko, T. Hiraga, K. Sasaki, and H. Narimatsu
Expression Cloning and Characterization of a Novel Murine alpha 1,3-Fucosyltransferase, mFuc-TIX, That Synthesizes the Lewis x (CD15) Epitope in Brain and Kidney
J. Biol. Chem.,
October 9, 1998;
273(41):
26729 - 26738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Sherwood, A. T. Nguyen, J. M. Whitaker, B. A. Macher, M. R. Stroud, and E. H. Holmes
Human alpha 1,3/4-Fucosyltransferases. III. A LYS/ARG RESIDUE LOCATED WITHIN THE alpha 1,3-FucT MOTIF IS REQUIRED FOR ACTIVITY BUT NOT SUBSTRATE BINDING
J. Biol. Chem.,
September 25, 1998;
273(39):
25256 - 25260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.A. Kukuruzinska and K. Lennon
Protein N-Glycosylation: Molecular Genetics and Functional Significance
Critical Reviews in Oral Biology & Medicine,
January 1, 1998;
9(4):
415 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Costache, P.-A. Apoil, A. Cailleau, A. Elmgren, G. Larson, S. Henry, A. Blancher, D. Iordachescu, R. Oriol, and R. Mollicone
Evolution of Fucosyltransferase Genes in Vertebrates
J. Biol. Chem.,
November 21, 1997;
272(47):
29721 - 29728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Martin, M. R. Edbrooke, T. C. Hodgman, D. H. van den Eijnden, and M. I. Bird
Lewis X Biosynthesis in Helicobacter pylori. MOLECULAR CLONING OF AN alpha (1,3)-FUCOSYLTRANSFERASE GENE
J. Biol. Chem.,
August 22, 1997;
272(34):
21349 - 21356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ge, N. W. C. Chan, M. M. Palcic, and D. E. Taylor
Cloning and Heterologous Expression of an alpha 1,3-Fucosyltransferase Gene from the Gastric Pathogen Helicobacter pylori
J. Biol. Chem.,
August 22, 1997;
272(34):
21357 - 21363.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|